Get started
Author

Gulshan Ara

Observed names: G ARA, G Ara
Observed institution: Dana-Farber Cancer Institute
OpenAlex ID: A5111601855
Potentiation of cytotoxic cancer therapies by TNP‐470 alone and with other anti‐angiogenic agents
1994 · Beverly A. Teicher, Sylvia A. Holden, et al. · International Journal of Cancer · 231
Transforming growth factor-β in in vivo resistance
1996 · B. A. Teicher, Sylvia A. Holden, et al. · Cancer Chemotherapy and Pharmacology · 49
Interaction of topoisomerase I inhibitors with radiation in cis‐diamminedichloroplatinum(II)‐sensitive and ‐resistantcells In Vitro and in the fsaiic fibrosarcoma In Vivo
1993 · Roseanne E. Bosciai, Timothy Korbut, et al. · International Journal of Cancer · 47
Optimal scheduling of interleukin 12 and chemotherapy in the murine MB-49 bladder carcinoma and B16 melanoma.
1997 · B A Teicher, G Ara, et al. · PubMed · 34
Optimal scheduling of interleukin-12 and fractionated radiation therapy in the murine lewis lung carcinoma
1998 · Beverly A. Teicher, Gulshan Ara, et al. · Radiation Oncology Investigations · 19
Allosteric effectors of hemoglobin as modulators of chemotherapy and radiation therapy in vitro and in vivo
1998 · Beverly A. Teicher, Julia S. Wong, et al. · Cancer Chemotherapy and Pharmacology · 18
Modulation of antitumor alkylating agents by novobiocin, topotecan, and lonidamine
1993 · Gary N. Schwartz, Beverly A. Teicher, et al. · Cancer Chemotherapy and Pharmacology · 13
Etanidazole as a Modulator of Combined Modality Therapy in the Rat 9l-gliosarcoma
1992 · BA TEICHER, SA HOLDEN, et al. · International Journal of Oncology · 10
Interaction of interleukin-11 with cytotoxic therapiesin vitro against CEM cells andin vivo against EMT-6 murine mammary carcinoma
1996 · Beverly A. Teicher, Ying-nan Chen, et al. · International Journal of Cancer · 6
PDF
Works count: 9
Citation count: 427
H-index: 8
I10-index: 8
Year
Topic
Type